TABLE 3

Single-dose pharmacokinetic proportionality study of PNU-288034 in rats

Indicated doses were administered to rats by oral gavage. Plasma was collected to 24 h after dose and analyzed by LC-MS/MS. Pharmacokinetic parameters were calculated from concentration-time curves as described under Materials and Methods.

DoseCmaxTmaxt1/2MRTAUC0-∞Unchanged in UrineF
mg/kgμg/mlhhhμg × h/ml%%
21.39.10 ± 2.00.5 ± 0.05.9 ± 1.42.63 ± 0.2613.9 ± 0.873.2 ± 6.473.3 ± 9.3
30.610.9 ± 9.20.25 ± 0.009.6 ± 2.46.70 ± 4.524.1 ± 4.372.5 ± 0.888.0 ± 19
6015.1 ± 1.60.75 ± 0.357.3 ± 3.43.78 ± 0.8042.5 ± 3.963.9 ± 4.079.5 ± 6.0
107.920.7 ± 0.40.38 ± 0.185.9 ± 3.54.50 ± 1.155.8 ± 8.650.8 ± 2.453.2 ± 8.0